Nancy Devlin : Citation Profile

Are you Nancy Devlin?

University of Melbourne (47% share)
University of Sheffield (47% share)
Office of Health Economics (6% share)

16

H index

20

i10 index

779

Citations

RESEARCH PRODUCTION:

67

Articles

52

Papers

4

Books

RESEARCH ACTIVITY:

   28 years (1994 - 2022). See details.
   Cites by year: 27
   Journals where Nancy Devlin has often published
   Relations with other researchers
   Recent citing documents: 53.    Total self citations: 71 (8.35 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde347
   Updated: 2022-09-24    RAS profile: 2022-08-14    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Shah, Koonal (18)

Feng, Yan (8)

Cubi-Molla, Patricia (3)

Zamora Talaya, Bernarda (3)

Mott, David (3)

Hampson, Grace (3)

Parkin, David (3)

Brazier, John (2)

Cole, Amanda (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin.

Is cited by:

Attema, Arthur (23)

Brouwer, Werner (22)

Brazier, John (16)

Gutacker, Nils (15)

Siciliani, Luigi (14)

Tsuchiya, Aki (13)

Shah, Koonal (12)

Towse, Adrian (11)

Street, Andrew (10)

Blankart, Katharina (10)

Viney, Rosalie (9)

Cites to:

Shah, Koonal (69)

Parkin, David (51)

Tsuchiya, Aki (41)

Feng, Yan (35)

Brazier, John (29)

Rice, Nigel (22)

Culyer, Anthony (14)

Roberts, Jennifer (14)

Brouwer, Werner (10)

Street, Andrew (9)

Claxton, Karl (8)

Main data

Where Nancy Devlin has published?

Journals with more than one article published# docs
Health Economics16
PharmacoEconomics13
The European Journal of Health Economics12
Health Policy6
Social Science & Medicine4
Applied Health Economics and Health Policy4
The Patient: Patient-Centered Outcomes Research2
PharmacoEconomics - Open2

Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics27
Working Papers / Department of Economics, City University London11
Consulting Reports / Office of Health Economics6
Working Papers / Centre for Health Economics, University of York5

Recent works citing Nancy Devlin (2022 and 2021)

YearTitle of citing document
2021Paying for health gains. (2021). Chalkley, Martin ; Gravelle, Hugh ; Gutacker, Nils ; Gaughan, James ; Siciliani, Luigi. In: Working Papers. RePEc:chy:respap:183cherp.

Full description at Econpapers || Download paper

2021The landscape of econometric discrete choice modelling research. (2021). , Michiel ; Haghani, Milad ; Hensher, David A. In: Journal of choice modelling. RePEc:eee:eejocm:v:40:y:2021:i:c:s1755534521000361.

Full description at Econpapers || Download paper

2021Joint modelling of choice and rating data: Theory and examples. (2021). Hess, Stephane. In: Journal of choice modelling. RePEc:eee:eejocm:v:40:y:2021:i:c:s1755534521000373.

Full description at Econpapers || Download paper

2021The effect of contract methods on the lead time of a two-level photovoltaic supply chain: revenue-sharing vs. cost-sharing. (2021). Zhang, Qin ; Zhao, Jing. In: Energy. RePEc:eee:energy:v:231:y:2021:i:c:s0360544221011786.

Full description at Econpapers || Download paper

2021Creating a priority list of non-communicable diseases to support health research funding decision-making. (2021). Babashahi, Saeideh ; Sullivan, Trudy ; Hansen, Paul. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:2:p:221-228.

Full description at Econpapers || Download paper

2022How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. (2022). Boes, Stefan ; Wettstein, Dominik J. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:2:p:112-121.

Full description at Econpapers || Download paper

2021Eliciting a monetary threshold for a year of sufficient capability to inform resource allocation decisions in public health and social care. (2021). Afentou, Nafsika ; Kinghorn, Philip. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003099.

Full description at Econpapers || Download paper

2021Mental health spillovers from serious family illness: Doubly robust estimation using EQ-5D-5L population normative data. (2021). Cullinan, John ; Henry, Edward. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003282.

Full description at Econpapers || Download paper

2021Quality of care experience in aged care: An Australia-Wide discrete choice experiment to elicit preference weights. (2021). Khadka, Jyoti ; Milte, Rachel ; Ratcliffe, Julie ; Chen, Gang ; Kaambwa, Billingsley. In: Social Science & Medicine. RePEc:eee:socmed:v:289:y:2021:i:c:s0277953621007723.

Full description at Econpapers || Download paper

2022An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. (2022). Jommi, Claudio ; Roudijk, Bram ; Ciani, Oriana ; Meregaglia, Michela ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:292:y:2022:i:c:s0277953621008510.

Full description at Econpapers || Download paper

2022The QALY at 50: One story many voices. (2022). Clarke, Philip ; Lloyd, Andrew ; Norman, Richard ; Edwards, Rhiannon Tudor ; Bleichrodt, Han ; Tsuchiya, Aki ; Wong, Ruth ; Rivero-Arias, Oliver ; Spencer, Anne. In: Social Science & Medicine. RePEc:eee:socmed:v:296:y:2022:i:c:s0277953621009850.

Full description at Econpapers || Download paper

2022Is higher quality always costly? Marginal costs of quality: Theory and application to railway punctuality. (2022). Cabral, Manuel Ojeda. In: Transportation Research Part A: Policy and Practice. RePEc:eee:transa:v:157:y:2022:i:c:p:258-273.

Full description at Econpapers || Download paper

2022The relevance of including future healthcare costs in cost-effectiveness threshold calculations for the UK NHS. (2021). Perry-Duxbury, Megan ; van Baal, Pieter ; Asaria, Miqdad ; Lomas, James. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:112503.

Full description at Econpapers || Download paper

2021Changing Energy Supplier on the Market with a Strong Position of Incumbent Suppliers—Polish Example. (2021). Bondos, Ilona ; Lipowski, Marcin ; Dudek, Dariusz. In: Energies. RePEc:gam:jeners:v:14:y:2021:i:13:p:3933-:d:586192.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Government Spending and Economic Growth: A Cointegration Analysis on Romania. (2021). Diaconu, Laura ; Popescu, Cristian C. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:12:p:6575-:d:571659.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data. (2021). Pedersen, Kjeld Moller ; Jensen, Morten Berg ; Gudex, Claire ; Sorensen, Sabrina Storgaard ; Ehlers, Lars Holger. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:4:d:10.1007_s40258-021-00639-3.

Full description at Econpapers || Download paper

2021How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13. (2021). Martin, Stephen ; Longo, Francesco ; Claxton, Karl ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00663-3.

Full description at Econpapers || Download paper

2022Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9.

Full description at Econpapers || Download paper

2022Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. (2022). Afzali, Hossein ; Partington, Andrew ; Karnon, Jonathan. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00681-1.

Full description at Econpapers || Download paper

2022Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents. (2022). Burstrom, Kristina ; Rolfson, Ola. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00713-w.

Full description at Econpapers || Download paper

2021Making Nature Explicit in Children’s Drawings of Wellbeing and Happy Spaces. (2021). Walshe, Nicola ; Moula, Zoe ; Lee, Elsa. In: Child Indicators Research. RePEc:spr:chinre:v:14:y:2021:i:4:d:10.1007_s12187-021-09811-6.

Full description at Econpapers || Download paper

2021Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. (2021). Kohlmann, Thomas ; Jiang, Ruixuan ; Pickard, Simon A ; Walton, Surrey ; shaw, james ; Muhlbacher, Axel ; Lee, Todd A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01224-6.

Full description at Econpapers || Download paper

2021Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. (2021). Thabane, Lehana ; Levine, Mitchell ; Krahn, Murray ; Brazier, John E ; Husereau, Don ; Lloyd, Andrew ; Ollendorf, Daniel ; Pickard, Simon A ; Xie, Feng ; Zoratti, Michael J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:5:d:10.1007_s10198-021-01286-0.

Full description at Econpapers || Download paper

2021Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies. (2021). Shen, Anle ; Zhou, Wenjing ; Luo, Nan ; Herdman, Michael ; Wu, Bin ; Wang, Pei ; Yang, Zhihao. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:7:d:10.1007_s10198-021-01309-w.

Full description at Econpapers || Download paper

2021Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states. (2021). Attema, Arthur ; Lipman, S A ; Jakubczyk, M ; Karimi, M ; Reckers-Droog, V T. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:9:d:10.1007_s10198-021-01377-y.

Full description at Econpapers || Download paper

2022Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?. (2022). Brouwer, Werner ; Exel, Job ; Himmler, Sebastian. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:1:d:10.1007_s10198-021-01353-6.

Full description at Econpapers || Download paper

2022Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis. (2022). Taylor, Rod S ; Warren, Fiona ; Lennox, Charlotte ; Kirkpatrick, Tim ; Anderson, Rob ; Hunter, Rachael Maree ; Byng, Richard ; Maguire, Mike ; Stirzaker, Alex ; Haddad, Mark ; Shaw, Jenny . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01360-7.

Full description at Econpapers || Download 2022

Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression. (2022). Poder, Thomas G ; Christian, . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01364-3.

Full description at Econpapers || Download paper

2022Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. (2022). Greiner, Wolfgang ; Marten, Ole. In: Health Economics Review. RePEc:spr:hecrev:v:12:y:2022:i:1:d:10.1186_s13561-022-00374-y.

Full description at Econpapers || Download paper

2021Empirical Validity of a Generic, Preference-Based Capability Wellbeing Instrument (ICECAP-A) in the Context of Spinal Cord Injury. (2021). , David ; David, ; Bryan, Stirling ; Noonan, Vanessa K ; Mah, Cassandra. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:2:d:10.1007_s40271-020-00451-6.

Full description at Econpapers || Download paper

2021QALYs for COVID-19: A Comparison of US EQ-5D-5L Value Sets. (2021). Poteet, Stephen ; Craig, Benjamin M. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:3:d:10.1007_s40271-021-00509-z.

Full description at Econpapers || Download paper

2021The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment. (2021). Meregaglia, Michela ; Whittal, Amanda ; Nicod, Elena. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:5:d:10.1007_s40271-020-00493-w.

Full description at Econpapers || Download paper

2021A New Approach to Assessing Children’s Interpretation of Severity Qualifiers in a Multi-Attribute Utility Instrument–The EQ-5D-Y-5L: Development and Testing. (2021). Herdman, Mike ; Derrett, Sarah ; Jelsma, Jennifer ; Moore, Elizabeth Yohe ; Ngwira, Lucky G. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:5:d:10.1007_s40271-021-00496-1.

Full description at Econpapers || Download paper

2021Valuing SF-6Dv2 in Australia Using an International Protocol. (2021). Brazier, John ; Norman, Richard ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01043-4.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

2021NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

Full description at Econpapers || Download paper

2021EQ-5D-Y Value Set for Slovenia. (2021). Ogorevc, Marko ; Rupel, Valentina Prevolnik. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00994-4.

Full description at Econpapers || Download paper

2022The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS. (2022). Asaria, Miqdad ; Baal, Pieter ; Lomas, James ; Perry-Duxbury, Megan. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01090-x.

Full description at Econpapers || Download paper

2022Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol. (2022). Revill, Paul ; Seeley, Janet ; Greco, Giulia ; Lamorde, Mohammed ; Ochanda, Perez N ; Griffin, Susan ; Yang, Zhihao ; Roudijk, Bram ; Katumba, Kenneth R ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:3:d:10.1007_s40273-021-01101-x.

Full description at Econpapers || Download paper

2022NICE and the EQ-5D-5L: Ten Years Trouble. (2022). Sampson, Christopher. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:1:d:10.1007_s41669-021-00315-1.

Full description at Econpapers || Download paper

2022Examining the Association between Polish Migrant Status and Health Preferences Using a Novel Application of a Smaller Design EQ-5D-5L Valuation Study. (2022). Oneill, Ciaran ; Baio, Gianluca ; Doherty, Edel ; Kharroubi, Samer ; Kelleher, Dan. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00314-2.

Full description at Econpapers || Download paper

2022Investigating the causal relationship between womans health and economic growth in groups D8 and G7 countries. (2022). Sojoodi, Sakineh ; Panahi, Hossein ; Jalili, Aylar. In: Quality & Quantity: International Journal of Methodology. RePEc:spr:qualqt:v:56:y:2022:i:1:d:10.1007_s11135-021-01133-7.

Full description at Econpapers || Download paper

2022Evaluating Health Related Quality of Life in Older People at Risk of Osteoporotic Fracture: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-6D. (2022). Jiang, Yutong ; Zhang, XI ; Yang, Mingcan ; Hiligsmann, Mickael ; Chen, Gang ; Xie, YA ; Palmer, Andrew J ; Tu, Liudan ; Gu, Jieruo ; Si, Lei ; Wei, Qiujing. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:160:y:2022:i:2:d:10.1007_s11205-020-02414-8.

Full description at Econpapers || Download 2021

Health expenditure and economic growth in Sub-Saharan Africa: An empirical investigation. (2021). Odhiambo, Nicholas M. In: Working Papers. RePEc:uza:wpaper:27167.

Full description at Econpapers || Download paper

2021Health expenditure and economic growth in Sub-Saharan Africa: An empirical investigation. (2021). Odhiambo, Nicholas M. In: Working Papers. RePEc:uza:wpaper:28863.

Full description at Econpapers || Download paper

2021Social tariffs and democratic choice—Do population?based health state values reflect the will of the people?. (2021). Schneider, Paul Peter. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:104-112.

Full description at Econpapers || Download paper

2021Estimating optimal willingness to pay thresholds for cost?effectiveness analysis: A generalized method. (2021). Cinatl, Chris ; Phelps, Charles E. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:7:p:1697-1702.

Full description at Econpapers || Download paper

2021Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions. (2021). Husbands, Samantha ; Mitchell, Paul Mark ; Coast, Joanna ; Peters, Tim J ; Bailey, Cara ; Kinghorn, Philip ; Byford, Sarah. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:9:p:1990-2003.

Full description at Econpapers || Download paper

2022Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis). (2022). Norman, Richard ; Jonker, Marcel F. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:2:p:431-439.

Full description at Econpapers || Download paper

2022Mapping between EQ?5D?3L and EQ?5D?5L: A survey experiment on the validity of multi?instrument data. (2022). Pudney, Stephen ; Hernandezalava, Monica. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:6:p:923-939.

Full description at Econpapers || Download paper

2022Correcting for discounting and loss aversion in composite time trade?off. (2022). Versteegh, Matthijs M ; Attema, Arthur E ; Lipman, Stefan A. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:8:p:1633-1648.

Full description at Econpapers || Download paper

Works by Nancy Devlin:

YearTitleTypeCited
1995Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform.
[Full Text][Citation analysis]		article0
1994The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health.
[Citation analysis]		article0
2000The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers.
[Full Text][Citation analysis]		paper4
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]		paper21
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK?ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 21		article
2012Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers.
[Full Text][Citation analysis]		paper1
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper49
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]		paper29
2013The Influence of Cost-effectiveness and Other Factors on NICE Decisions.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 29		paper
2015The Influence of Cost?Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 29		article
2003Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis In: Working Papers.
[Full Text][Citation analysis]		paper3
2004Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis? In: Working Papers.
[Full Text][Citation analysis]		paper2
2004A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study In: Working Papers.
[Full Text][Citation analysis]		paper0
2005Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models In: Working Papers.
[Full Text][Citation analysis]		paper1
2006The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis In: Working Papers.
[Full Text][Citation analysis]		paper0
2008A note on the nature of utility in time and health and implications for cost utility analysis In: Working Papers.
[Full Text][Citation analysis]		paper0
2008Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? In: Working Papers.
[Full Text][Citation analysis]		paper3
2009Using the EQ-5D as a performance measurement tool in the NHS In: Working Papers.
[Full Text][Citation analysis]		paper2
2009Does the value of quality of life depend on duration? In: Working Papers.
[Full Text][Citation analysis]		paper2
2009A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Working Papers.
[Full Text][Citation analysis]		paper1
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients In: Working Papers.
[Full Text][Citation analysis]		paper2
2015Local health care expenditure plans and their opportunity costs In: Health Policy.
[Full Text][Citation analysis]		article5
2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy.
[Full Text][Citation analysis]		article1
2020The impact of price transparency on consumers and providers: A scoping review In: Health Policy.
[Full Text][Citation analysis]		article1
1996The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy.
[Full Text][Citation analysis]		article8
2006Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy.
[Full Text][Citation analysis]		article7
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]		article25
2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine.
[Full Text][Citation analysis]		article3
1999The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine.
[Full Text][Citation analysis]		article3
2005Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine.
[Full Text][Citation analysis]		article9
2009A note on the nature of utility in time and health and implications for cost utility analysis In: Social Science & Medicine.
[Full Text][Citation analysis]		article4
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]		article32
2000Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series.
[Full Text][Citation analysis]		paper0
2016New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings.
[Full Text][Citation analysis]		paper0
2012Time Trends in NICE HTA Decisions In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response In: Consulting Reports.
[Full Text][Citation analysis]		paper6
2015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports.
[Full Text][Citation analysis]		paper3
2016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making In: Consulting Reports.
[Full Text][Citation analysis]		paper2
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]		paper1
2011Incorporating Multiple Criteria in HTA: Methods and Processes In: Monographs.
[Full Text][Citation analysis]		book24
2010Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monographs.
[Full Text][Citation analysis]		book20
2002Cost-Effectiveness Thresholds: Economic and ethical issues In: Monographs.
[Full Text][Citation analysis]		book18
2004How Much Should We Spend on the NHS? In: Monographs.
[Full Text][Citation analysis]		book2
2013Searching for Cost-effectiveness Thresholds in NHS Scotland In: Research Papers.
[Full Text][Citation analysis]		paper0
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinsons Disease Patients In: Research Papers.
[Full Text][Citation analysis]		paper1
2012Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers.
[Full Text][Citation analysis]		paper3
2012Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Papers.
[Full Text][Citation analysis]		paper2
2011Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches In: Research Papers.
[Full Text][Citation analysis]		paper1
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers.
[Full Text][Citation analysis]		paper1
2010A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers.
[Full Text][Citation analysis]		paper16
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 16		article
2014Opportunity Costs of Implementing NICE Decisions in NHS Wales In: Research Papers.
[Full Text][Citation analysis]		paper1
2014What Determines the Shape of an EQ-5D Index Distribution? In: Research Papers.
[Full Text][Citation analysis]		paper4
2016What Determines the Shape of an EQ-5D Index Distribution?.(2016) In: Medical Decision Making.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 4		article
2015An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers.
[Full Text][Citation analysis]		paper72
2018Valuing health?related quality of life: An EQ?5D?5L value set for England.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 72		article
2016New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers.
[Full Text][Citation analysis]		paper14
2018New methods for modelling EQ?5D?5L value sets: An application to English data.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14		article
2016A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers.
[Full Text][Citation analysis]		paper4
2016The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers.
[Full Text][Citation analysis]		paper0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0		article
2016An Analysis of NICE Technology Appraisal Decisions Recommended in Line with Clinical Practice In: Research Papers.
[Full Text][Citation analysis]		paper0
2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers.
[Full Text][Citation analysis]		paper1
2017Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers.
[Full Text][Citation analysis]		paper4
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 4		article
2017Age and Utilities: Issues for HTA In: Research Papers.
[Full Text][Citation analysis]		paper0
2017A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers.
[Full Text][Citation analysis]		paper1
2018New Methods for Analysing the Distribution of EQ-5D Observations In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA In: Research Papers.
[Full Text][Citation analysis]		paper1
2019Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers.
[Full Text][Citation analysis]		paper3
2020Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead In: Research Papers.
[Full Text][Citation analysis]		paper0
2020Drop Dead: Is Anchoring at Dead a Theoretical Requirement in Health State Valuation? In: Research Papers.
[Full Text][Citation analysis]		paper1
2012Time to tweak the TTO. But how? In: MPRA Paper.
[Full Text][Citation analysis]		paper1
2010Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making.
[Full Text][Citation analysis]		article4
2010Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review In: Medical Decision Making.
[Full Text][Citation analysis]		article10
2013Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions In: Medical Decision Making.
[Full Text][Citation analysis]		article10
2017EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article18
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article3
2021Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article1
2021EQ-5D-5L Health-State Values for the Mexican Population In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article1
2013The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article9
2013The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2013Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2017Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2019Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article5
2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2021What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2005A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2017Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2021Giving a Voice to Marginalised Groups for Health Care Decision Making In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2013Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics.
[Full Text][Citation analysis]		article12
2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]		article4
20183L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2018Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2020International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2022How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2022A Comparison of PROPr and EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2022Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2019All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open.
[Full Text][Citation analysis]		article0
2001Health care spending and economic output: Granger causality In: Applied Economics Letters.
[Full Text][Citation analysis]		article50
2002The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics.
[Full Text][Citation analysis]		article0
2003Logical inconsistencies in survey respondents health state valuations ? a methodological challenge for estimating social tariffs In: Health Economics.
[Full Text][Citation analysis]		article19
2004Does NICE have a cost?effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]		article104
2004Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1?85775?575?8 In: Health Economics.
[Full Text][Citation analysis]		article0
2006A theoretical framework for TTO valuations of health In: Health Economics.
[Full Text][Citation analysis]		article6
2006Is there a case for using visual analogue scale valuations in cost?utility analysis? In: Health Economics.
[Full Text][Citation analysis]		article29
2007‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics.
[Full Text][Citation analysis]		article0
2010Patient?reported outcome measures in the NHS: new methods for analysing and reporting EQ?5D data In: Health Economics.
[Full Text][Citation analysis]		article9
2011A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Health Economics.
[Full Text][Citation analysis]		article27
2015INTER?PROVIDER COMPARISON OF PATIENT?REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]		article2
2021Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia In: Health Economics.
[Full Text][Citation analysis]		article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team